GPI Global Pricing Innovations
At GPI, our work is centred around our FOUR core values: Quality Matters, Sustainability, Authenticity and Collaboration. Every day, our amazing staff go above and beyond for our customers and strive to maintain the high quality standards and values that GPI stands for.
Read MoreGPI is thrilled to announce the launch of a brand-new website, www.globalpricing.com. The website has been re-designed for our users, to reflect GPI’s innovative approach to pricing and market access solutions and to showcase the new features of the data analytics platform GPI pulse™ 2.0.
Read MoreAt GPI, our work is centred around our FOUR core values: Quality Matters, Sustainability, Authenticity and Collaboration. Every day, our amazing staff go above and beyond for our customers and strive to maintain the high quality standards and values that GPI stands for.
Read MoreAt GPI, our work is centred around our FOUR core values: Quality Matters, Sustainability, Authenticity and Collaboration. Every day, our amazing staff go above and beyond for our customers and strive to maintain the high quality standards and values that GPI stands for.
Read MoreHow you price your drugs is a big and important decision.
Read MoreAt GPI, our work is centred around our FOUR core values: Quality Matters, Sustainability, Authenticity and Collaboration. Every day, our amazing staff go above and beyond for our customers and strive to maintain the high quality standards and values that GPI stands for.
Read MoreThe French state-industry drug framework agreement stipulates that innovative products manufactured in the country can have the same initial price as the highest one applied in Germany, the UK, Italy, or Spain The new 2021-24 framework agreement signed on Friday 5th March between France’s healthcare products committee CEPS and French pharma body Leem includes a…
Read MoreRecently Spain’s medicines regulatory bodies announced the requirement of additional “economic evaluation” data for therapeutics positioning reports (IPTs) which is the equivalent of a Health Technology Assessment process in the country. This change is part of a revolution of the overall HTA process in 2021 which will include 12 steps, proposed to reduce the time…
Read MorePfizer and BioNTech have announced positive interim Phase III results for their mRNA-based COVID-19 vaccine, BNT162b2, suggesting that it is 90% effective in preventing infection.
Read MoreCanada is due to adjust its international reference pricing (#IRP) basket of comparator countries come January, the 1st, 2021.
Read More